Cognizant Technology Solutions (NASDAQ:CTSH – Get Free Report) had its target price hoisted by research analysts at Deutsche Bank Aktiengesellschaft from $70.00 to $80.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “hold” rating on the information technology service provider’s stock. Deutsche Bank Aktiengesellschaft’s price target would […]

Investment analysts at Susquehanna began coverage on shares of BKV (NYSE:BKV – Get Free Report) in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage set a “positive” rating and a $24.00 price target on the stock. Susquehanna’s price target would indicate a potential upside of 29.94% from the company’s […]

StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report sent to investors on Friday. The brokerage issued a hold rating on the stock. A number of other research firms have also weighed in on ONCT. Brookline Capital Management reaffirmed a “hold” rating on shares of Oncternal Therapeutics in […]

Needham & Company LLC reaffirmed their buy rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report sent to investors on Friday, Benzinga reports. Needham & Company LLC currently has a $23.00 target price on the stock. Several other research firms also recently weighed in on NMRA. HC Wainwright started coverage […]

AES (NYSE:AES – Get Free Report) had its price target increased by equities research analysts at Barclays from $22.00 to $23.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the utilities provider’s stock. Barclays‘s price objective suggests a potential upside of 30.98% from the stock’s previous […]

Research analysts at Citigroup started coverage on shares of BKV (NYSE:BKV – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set a “buy” rating and a $29.00 price target on the stock. Citigroup’s price objective would suggest a potential upside of 56.17% from the stock’s previous close. BKV has […]